Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
23.29
+0.37 (1.61%)
Oct 8, 2025, 9:54 AM EDT - Market open
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$455,018
Profits / Employee
-$12,439
Market Cap
675.60M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 761 | 151 | 24.75% |
Dec 31, 2023 | 610 | 67 | 12.34% |
Dec 31, 2022 | 543 | 198 | 57.39% |
Dec 31, 2021 | 345 | 144 | 71.64% |
Dec 31, 2020 | 201 | 66 | 48.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CSTL News
- 6 days ago - Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - GlobeNewsWire
- 15 days ago - Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - GlobeNewsWire
- 21 days ago - Castle Biosciences Named One of Newsweek's America's Greatest Companies 2025 - GlobeNewsWire
- 4 weeks ago - New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett's Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions - GlobeNewsWire
- 5 weeks ago - Castle Biosciences: Strong Margins, Solid Balance Sheet, And Big Upside Potential - Seeking Alpha
- 6 weeks ago - New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma - GlobeNewsWire
- 6 weeks ago - Castle Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Castle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call Transcript - Seeking Alpha